Every batch third-party tested · Discreet nationwide shipping

CJC-1295 vs. Sermorelin

4 min read

CJC-1295 and sermorelin are closer relatives than most compound pairs discussed together: both are GHRH analogs. The practical differences are duration and approval status.

Same class

Both act at the GHRH receptor, the same target as the body's own growth-hormone-releasing hormone.

Sermorelin corresponds closely to the natural GHRH fragment. CJC-1295 is a modified analog designed in research for greater stability.

Duration is the practical difference

Sermorelin's short half-life means a brief signal after administration.

CJC-1295 was engineered for a longer duration of action, which is the main reason the two are studied differently. Longer action changes dosing cadence — a clinical decision, not a preference.

Regulatory standing

Sermorelin is a prescription medication with established clinical characterization. CJC-1295 has not been through that pathway and appears primarily in research contexts.

For anyone evaluating options, that distinction is more consequential than the pharmacokinetic comparison.

Nothing is dispensed without a provider review.

Talk to a licensed provider

Keep reading

Sermorelin vs. Ipamorelin

Read

What Is Peptide Therapy?

Read

Educational content only. Nothing here is medical advice or a claim to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the Food and Drug Administration. Products are dispensed only pursuant to a valid prescription issued by a licensed provider.